[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1053788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 858245, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.281, "open": 7.4, "dayLow": 7.1, "dayHigh": 7.4, "regularMarketPreviousClose": 7.281, "regularMarketOpen": 7.4, "regularMarketDayLow": 7.1, "regularMarketDayHigh": 7.4, "payoutRatio": 0.0, "beta": 1.824, "trailingPE": 0.007512022, "forwardPE": -5.95157, "volume": 1544, "regularMarketVolume": 1544, "averageVolume": 8127, "averageVolume10days": 3390, "averageDailyVolume10Day": 3390, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4235625, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 54.95, "fiftyDayAverage": 8.16352, "twoHundredDayAverage": 12.39991, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 143080320, "profitMargins": 0.0, "floatShares": 4128079, "sharesOutstanding": 588167, "sharesShort": 9000, "sharesShortPriorMonth": 10043, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0153, "heldPercentInsiders": 0.00202, "heldPercentInstitutions": 0.00162, "shortRatio": 2.14, "shortPercentOfFloat": 0.0165, "impliedSharesOutstanding": 20585800, "bookValue": 4.338, "priceToBook": 1.6600738, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12169276, "trailingEps": 958.65, "forwardEps": -1.21, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -11.371, "52WeekChange": -0.6805235, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 7.2014, "targetHighPrice": 70.0, "targetLowPrice": 25.0, "targetMeanPrice": 40.66667, "targetMedianPrice": 27.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 7790322, "totalCashPerShare": 0.378, "ebitda": -12583419, "totalDebt": 2623733, "quickRatio": 1.796, "currentRatio": 1.955, "debtToEquity": 102.837, "returnOnAssets": -0.6903, "returnOnEquity": -2.42665, "freeCashflow": -6159128, "operatingCashflow": -10696324, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "esgPopulated": false, "marketState": "CLOSED", "regularMarketChangePercent": -1.093261, "regularMarketPrice": 7.2014, "corporateActions": [], "fiftyDayAverageChange": -0.96212006, "fiftyDayAverageChangePercent": -0.11785603, "twoHundredDayAverageChange": -5.19851, "twoHundredDayAverageChangePercent": -0.41923773, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Cellect Biotechnology Ltd.", "nameChangeDate": "2025-08-22", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketPrice": 7.2, "postMarketChange": -0.0013999939, "regularMarketChange": -0.079600334, "regularMarketDayRange": "7.1 - 7.4", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 8127, "fiftyTwoWeekLowChange": 2.1913996, "fiftyTwoWeekLowChangePercent": 0.43740508, "fiftyTwoWeekRange": "5.01 - 54.95", "fiftyTwoWeekHighChange": -47.7486, "fiftyTwoWeekHighChangePercent": -0.8689463, "fiftyTwoWeekChangePercent": -68.05235, "dividendDate": 1571788800, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 958.65, "epsForward": -1.21, "epsCurrentYear": -11.6, "priceEpsCurrentYear": -0.62081033, "postMarketTime": 1755893449, "regularMarketTime": 1755892800, "market": "us_market", "postMarketChangePercent": -0.01944058, "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]